Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1998-10-23
2000-10-31
Spear, James M.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424449, 424443, 424423, 514170, 514841, 514843, A61K 920, A61K 3156
Patent
active
06139873&
ABSTRACT:
Disclosed are methods and compositions for oral contraception and for hormone replacement therapy. Certain compositions of the invention contain androgens, preferably methyltestosterone to be taken in conjunction with estrogens and progestins.
REFERENCES:
patent: 4220599 (1980-09-01), Van Der Vies
patent: 5211952 (1993-05-01), Spicer et al.
patent: 5340584 (1994-08-01), Spicer et al.
patent: 5595759 (1997-01-01), Wright et al.
patent: 5770226 (1998-06-01), Hughes, Jr. et al.
patent: 5962021 (1999-10-01), Hughes, Jr. et al.
The Contraception Report, Baylor College of Medicine, vol. VI, No. 5, Nov. 1995.
Adams et al., "Effects of androgens on coronary atherosclerosis and atherosclerosis-related impairment of vascular responsiveness," Arterioscler. Thromb. Vasc. Biol., 15:562-70, 1995.
Adashi, "The climacteric ovary as a functionalgonadotropin-driven gonadropin-driven androgen-producing gland," Fertil. Steril., 62:20-27, 1994.
Barrett-Connor, "The economic and human costs of osteoporotic fracture," Am. J. Med., 98(Suppl. 2A):3S-8S, 1995.
Bubenik, et al., "The effect of artificial photoperiodicity and antiandrogen treatment on the antler growth and plasma levels of LH, FSH, testosterone, prolactin and alkaline phosphatase in the male white-tailed deer," Comp. Biochem. Physiol. A Comp. Physiol., 87:551-59, 1987.
Buchanan, et al., "Effects of excess endogenous androgens on bone density in young women," J. Clin. Endocrinol. Metab., 67:934-43, 1988.
Carr et al., "Oral contraceptive pills, gonadotropin-releasing hormone antagonists, or use in combination for treatment of hirsutism: A clinical research center study," J. Clin. Endocrin. Metab., 80:1169-78, 1995.
Castro et al., "Ketamine HCl as a suitable anesthetic for endocrine, metabolic, and cardiovascular studies in Macaca fascicularis monkeys," Proc. Soc. Exp. Biol. Med., 168:389-94, 1981.
Cauley et al., "Black-white differences in serum sex hormones and bone mineral density," Am. J. Epidemiol., 139:1035-46, 1994.
Clarkson, et al., "Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys," Obstet. Gynecol., 75:217-22, 1990.
Colvard, et al., "Identification of androgen receptors in normal human osteoblast-like cells," Proc. Natl. Acad. Sci. USA, 86:864-57, 1989.
DeCherney, "One-sparing properties of oral contraceptives," Am. J. Obstet. Gynecol., 174:1, 1993.
Duhper, et al., "Effects of hormonal status on bone density in adolescent girls," J. Clin. Endocrinol. Metab., 71:1083-88, 1990.
Enzelberger, et al., "Influence of oral contraceptive use on bone density in climacteric women," Maturitas , 9:375-8, 1988.
Flanagan, et al., "Casodex reduces bone formation rate in female rats," (Abstract), J. Bone Miner. Res., 10(Suppl I):S349, 1995.
Fortney, et al., "Bone mineral density and history of oral contraceptive use." J. Reprod Med 39:105-9, 1994.
Frank, "The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton," Acta Paediatr., 84:627-30, 1995.
Gallagher, et al., "Androgens contribute to the stimulation of cancellous bone formation by ovarian hormones in female rats," American Physiological Society, 270:E407-12, 1996.
Gallagher, et al., "Ovarian transplantation maintains bone formation more effectively than exogenous oestrogen in ovariectomised osteopenic rats," Department of Histopathology, St. George's Hospital Medical School, London. Jan. 96.
Gambacciani, et al., "Longitudinal evaluation of perimenopausal vertebral bone loss: effects of low dose oral contraceptive preparation on bone mineral density and metabolism," Obstet. Gynecol., 83:392-96, 1994.
Garnero, et al., "Decreased bone turnover in oral contraceptive users," Bone, 16(5):499-503, 1995.
Garnero, et al. "Genetic influence on bone turnover in postmenopausal twins," Journal of Clinical Endocrinology and Metabolism, 81(1): 140-6, 1996.
Goldsmith and Johnston, "Bone mineral: Effects of oral contraceptives, pregnancy, and lactation," J. Bone J. Surg., 57A:657-68, 1975.
Hickock, et al., "A comparison of esterified estrogens with and without methylestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women," Obstet. Gynecol., 82:919-24, 1993.
Hreshchyshyn, et al., "Association of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities," Am. J. Obstet. Gynecol. 159:318-22, 1988.
Hughes, et al., "Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause," Gynecol. Oncol, 40:42-5, 1991.
Jayo, et al., "Bone mass in female cynomolgus macaques: A cross-sectional and longitudinal study by age," Calcif. Tissue Int., 54:231-6, 1994.
Jayo, et al., "Accuracy and precision of lumbar bone mineral content by dual-energy X-ray absorptiometry in live female monkeys," Calcif. Tissue Int., 49:438-40, 1991.
Jayo, et al., "Effects of thiazide and estrogen on bone in ovariectomized monkeys," (Abstract), J. Bone Miner. Res., 10:S256, 1995.
Jayo, et al., "Anthropometry and bone mineral status in endocrinologically manipulated female cynomolgus macaques (Macaca fascicularis)," (Abstract), J. Bone Miner. Res., 4(Suppl. 1):S181, 1989.
Jayo, et al., "Effects on bone of surgical menopause and estrogen therapy with our without progesterone replacement in cynomolgus monkeys," Am. J. Obstet. Gynecol., 193:614-18, 1990.
Jayo, et al., "Cross-Sectional Examination of Lumbar Bone Mineral by Dual Energy X-Ray Absorptiometry (DXA) in Female Cynomolgus Macaques" S170 (Abstr. #348). Feb. 1990.
Jerome, et al., "Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry," J. Bone Miner. Res., 9:527-40, 1994.
Johnell and Nilsson, "Life-style and bone mineral mass in perimenopausal women." Calcif. Tissue Int., 36:354-56, 1984.
Kanders, et al., "Interaction of calcium nutrition and physical activity on bone mass in young women," J. Bone Miner. Res., 3:145-49, 1988.
Kanis, "Treatment of osteoporosis in elderly women," Am. J. Med., 98(Suppl. 2A):605-65, 1995.
Kasperk, et al., "Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone," J. Clin. Endocrinol. Metab., 71:1322-29, 1990.
Kasra and Grynpas, "The effects of androgens on the mechanical properties of primate bone," Bone, 17:265-70, 1995.
Polatti, et al., "Bone mass and long-term monophasic oral contraceptive treatment in young women," Contraception, 51:221-24, 1995.
Raisz, et al., "Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women," Journal of Clinical Endocrinology and Metabolism, 81(1):37-43, 1996.
Riasz, "The role of androgens in the pathogenesis and treatment of postmenopausal osteoporosis," The Female Patient, 11-18, 1996.
Recker, et al., "Bone gain in young adult women," JAMA, 268:2403-08, 1992.
Register, et al., "Oral contraceptive treatment inhibits normal bone mineral accretion and bone metabolism in young adult female macaques," (Abstract), J. Bone Min. Reser., 10(Suppl 1):S356, 1995.
Register, et al., "Oral Contraceptive Treatment Inhibits the Normal Acquisition of Bone Mineral in Skeletally Immature Young Adult Female Monkeys," Osteoporosis Int. 1997.
Ribot, et al., "Late consequences of a low peak bone mass," Acta. Paediatr. Suppl., 411:31-5, 1995.
Shargil, "Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: A three year prospective study." Int. J. Fertil. 30(1):15-28, 1985.
Shively, et al., "Body fat distribution as a risk factor for coronary artery atherosclerosis in female cynomolgus monkeys," Arteriosclerosis, 7:226-31, 1987.
Simberg, et al., "High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement," Journal of Clinical Endocrinology and Metabolism, 81(2):646-51, 1996.
Slemenda, et al., "Sex steroids, bone mass, and bone loss," J. Clin. Invest.
Hughes, Jr. Claude L.
Jayo Manuel J.
Cedars-Sinai Medical Center
Corder Timothy S.
Spear James M.
Wake Forest University
LandOfFree
Combined pharmaceutical estrogen-androgen-progestin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined pharmaceutical estrogen-androgen-progestin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined pharmaceutical estrogen-androgen-progestin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2048210